Naunyn Schmiedebergs Arch Pharmacol. 1994 Mar;349(3):295-300. doi: 10.1007/BF00169296.
Evidence for norepinephrine cardiotoxicity mediated by superoxide anion radicals in isolated rabbit hearts.
Naunyn-Schmiedeberg's archives of pharmacology
A F Rump, W Klaus
Affiliations
Affiliations
- Institut für Pharmakologie, Universität Köln, Germany.
PMID: 7911559
DOI: 10.1007/BF00169296
Abstract
UNLABELLED: Catecholamines have been demonstrated to be cardiotoxic. Besides hemodynamic alterations, oxygen free radicals generated by the auto-oxidation of catecholamines might contribute to their deleterious effects. We examined the influence of exogenous norepinephrine (NE), after inhibiting functional alterations by alpha and beta-adrenoceptor blockade, on acute regional ischemia (MI).
METHOD: We used isolated electrically-driven rabbit hearts with depleted catecholamine stores (reserpine 7.0 mg/kg i.p. 16-24 h before preparation, Langendorff, constant pressure: 70 cm H2O, Tyrode solution, Ca2+ 1.8 mmol/l, 37 degrees C, 185-200 beats/min). Repetitive MI, separated by a reperfusion period of 50 min, was induced by coronary artery branch ligature and quantitated from epicardial NADH-fluorescence photography. Starting after a reperfusion period of 20 min, isolated hearts were treated with NE (10(-6) M), in the presence of propranolol (10(-6) M), phentolamine (10(-6) M) and vitamin C (3 x 10(-8) M) in the perfusion buffer to prevent the functional effects of NE. The influence of the free radical scavenger superoxide dismutase (SOD) (30 U/ml) or captopril (10(-6) M) on MI was also examined.
RESULTS: Left ventricular pressure or coronary flow were not significantly affected by either treatment (p > 0.05). Epicardial NADH-fluorescence area and intensity were, however, significantly enhanced by NE (+22%) (P < 0.05), although propranolol, phentolamine and vitamin C had no significant influence on MI (P > 0.05). SOD had no significant effect on MI in control hearts (P > 0.05) but completely prevented MI enlargement by NE (P > 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
References
- Rev Can Biol. 1959 Apr;18(1):83-94 - PubMed
- Toxicol Lett. 1989 Jul;48(1):3-20 - PubMed
- Klin Wochenschr. 1991;69 Suppl 24:6-9 - PubMed
- Br Heart J. 1985 Aug;54(2):160-5 - PubMed
- Pharmacol Res. 1989 Nov-Dec;21 Suppl 2:57-65 - PubMed
- Clin Cardiol. 1979 Oct;2(5):317-27 - PubMed
- Am J Med. 1991 Sep 30;91(3C):95S-105S - PubMed
- Anesth Analg. 1993 Feb;76(2):239-46 - PubMed
- Eur Heart J. 1993 Jan;14(1):106-12 - PubMed
- Lab Invest. 1982 Nov;47(5):412-26 - PubMed
- AMA Arch Pathol. 1959 Apr;67(4):443-55 - PubMed
- Circ Res. 1989 Oct;65(4):1151-6 - PubMed
- Can J Physiol Pharmacol. 1982 Nov;60(11):1390-7 - PubMed
- Circulation. 1988 Jun;77(6 Pt 2):I30-9 - PubMed
- Circ Res. 1966 Dec;19(6):1050-61 - PubMed
- Naunyn Schmiedebergs Arch Pharmacol. 1990 Jan-Feb;341(1-2):50-5 - PubMed
- J Pharmacol Exp Ther. 1981 Oct;219(1):225-30 - PubMed
- Arzneimittelforschung. 1993 Dec;43(12):1262-6 - PubMed
- Circ Res. 1988 Jul;63(1):214-26 - PubMed
- J Mol Cell Cardiol. 1975 Nov;7(11):807-16 - PubMed
- J Mol Cell Cardiol. 1989 Dec;21(12):1261-71 - PubMed
- Rev Can Biol. 1963 Jun;22:241-55 - PubMed
- Circ Res. 1988 Jul;63(1):262-6 - PubMed
- J Mol Cell Cardiol. 1990 Oct;22(10):1199-208 - PubMed
Substances
MeSH terms
Publication Types